Trinity Biotech (TRIB) Equity Average (2009 - 2022)

Trinity Biotech's (TRIB) quarterly Equity Average came in at $2.2 million in Q4 2022, up 625.87% quarter-over-quarter from $307009.0 in Q2 2009.

Trinity Biotech (TRIB) Equity Average (2009 - 2022) Analysis & Trends

Trinity Biotech has disclosed Equity Average across 2 years of filings, most recently posting $2.2 million for Q4 2022.

Equity Average for Q4 2022 came in at $2.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $2.2 million (changed N/A YoY), and the FY2025 annual result was -$53.6 million, down 81.23% from the prior year.
Equity Average came in at $2.2 million for Q4 2022 at Trinity Biotech, up from $307009.0 in the prior quarter.
In the past five years, Equity Average ranged from a high of $2.2 million in Q4 2022 to a low of $2.2 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	52.42 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.70 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	49.03 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	25.17 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	10.33 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	13.05 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	2.85 Bn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.53 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	7.18 Bn
10	Trinity Biotech	23,520.00	-5.11 Mn	-	-

Download Data